{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:06:21Z","timestamp":1793034381133,"version":"4.5.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:p>To assess the effect of defocus incorporated multiple segments (DIMS) (Miyosmart) lenses on myopic progression in children not responding to low-concentration atropine (LCA) (0.01%) eye drops. A total of 10 children not responding to LCA (0.01%) eye drops were advised to start using the DIMS lens to halt the progression of myopia. The children were followed for a period of 1 year. Eight out of 10 children showed a reduction in the progression of myopia. Pre DIMS, the progression was \u22120.68 D \u00b1 0.3 D sph, which reduced to \u22120.24 \u00b1 0.2 diopter progression post DIMS lens in the eight children. The remaining two children still progressed by \u22120.57 \u00b1 0.4 D sph over a year. The axial length growth reduced from 0.28 \u00b1 0.3 mm to 0.16 \u00b1 0.2 mm after using the DIMS lens in these non-responders. The DIMS lens shows initial promise in reducing the progression of myopia even in children not responding to LCA 0.01% eye drops.<\/jats:p>","DOI":"10.4103\/ijo.ijo_2378_23","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T02:00:09Z","timestamp":1708653609000},"page":"S709-S711","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Effect of defocus incorporated multiple segments lenses on halting myopia progression not responding to low-concentration atropine (0.01%) eye drops"],"prefix":"10.4103","volume":"72","author":[{"given":"Jitendra","family":"Jethani","sequence":"first","affiliation":[{"name":"Baroda Children Eyecare and Squint Clinic, Vadodara, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"key":"R1-20260507","doi-asserted-by":"crossref","first-page":"228591.","DOI":"10.1016\/j.ophtha.2006.05.062","article-title":"Atropine for the treatment of childhood myopia","volume":"113","author":"Chua","year":"2006","journal-title":"Ophthalmology"},{"key":"R2-20260507","doi-asserted-by":"crossref","first-page":"34754.","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: Safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine forthe Treatment of Myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"key":"R3-20260507","doi-asserted-by":"crossref","first-page":"4517.","DOI":"10.1016\/j.ajo.2013.09.020","article-title":"Atropine for the treatment of childhood myopia: Changes after stopping atropine 0.01%, 0.1% and 0.5%","volume":"157","author":"Chia","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R4-20260507","doi-asserted-by":"crossref","first-page":"4248.","DOI":"10.1097\/APO.0000000000000232","article-title":"Topical atropine in the control of myopia","volume":"5","author":"Tan","year":"2016","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"R5-20260507","doi-asserted-by":"crossref","first-page":"146772.","DOI":"10.1097\/OPX.0000000000000037","article-title":"Maximum atropine dose without clinical signs or symptoms","volume":"90","author":"Cooper","year":"2013","journal-title":"Optom Vis Sci"},{"key":"R6-20260507","first-page":"3919.","article-title":"Fiveyear clinical trial on atropine for the treatment of myopia 2: Myopia control with atropine 0.01% eyedrops","volume":"123","author":"Chia","year":"2016","journal-title":"Ophthalmology"},{"key":"R7-20260507","doi-asserted-by":"crossref","first-page":"4269.","DOI":"10.1016\/j.jaapos.2015.04.006","article-title":"Therapeutic effect of atropine 1% in children with low myopia","volume":"19","author":"Yi","year":"2015","journal-title":"J AAPOS"},{"key":"R8-20260507","first-page":"17881","article-title":"Low Concentration Atropine (0.01%) to Control the Progression of Axial Myopia in Children","author":"Jethani","year":"2018","journal-title":"AIOS Proceedings"},{"key":"R9-20260507","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ophtha.2021.01.026","article-title":"Atropine for the treatment of childhood myopia in India: Multicentric randomized trial","volume":"128","author":"Saxena","year":"2021","journal-title":"Ophthalmology"},{"key":"R10-20260507","doi-asserted-by":"crossref","first-page":"25961.","DOI":"10.4103\/ijo.IJO_1938_19","article-title":"Comments on: Changes in pattern electroretinogram after application of 0.01% atropine eye drops","volume":"68","author":"Jethani","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"R11-20260507","doi-asserted-by":"crossref","first-page":"22301.","DOI":"10.4103\/ijo.IJO_3354_20","article-title":"Compliance in usage of lowdose Atropine for prevention of progression of myopia in Indian Children","volume":"69","author":"Dalal","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R12-20260507","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4103\/ijo.IJO_1462_21","article-title":"Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes","volume":"70","author":"Jethani","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"R13-20260507","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.visres.2009.07.011","article-title":"Relative peripheral hyperopic defocus alters central refractive development in infant monkeys","volume":"49","author":"Smith","year":"2009","journal-title":"Vision Res"},{"key":"R14-20260507","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.optom.2020.10.007","article-title":"Relationship between peripheral refraction, axial lengths and parental myopia of young adult myopes","volume":"15","author":"Koomson","year":"2022","journal-title":"J Optom"},{"key":"R15-20260507","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/OPX.0000000000001890","article-title":"Asymmetric peripheral refraction profile in myopes along the horizontal meridian","volume":"99","author":"Yelagondula","year":"2022","journal-title":"Optom Vis Sci"},{"key":"R16-20260507","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/OPX.0b013e3181ea19c7","article-title":"Spectacle lenses designed to reduce progression of myopia: 12-month results","volume":"87","author":"Sankaridurg","year":"2010","journal-title":"Optom Vis Sci"},{"key":"R17-20260507","first-page":"1197","article-title":"Safety of DIMS spectacle lenses and atropine as combination therapy for myopia progression","volume":"239","author":"Kaymak","year":"2022","journal-title":"Klin Monbl Augenheilkd"},{"key":"R18-20260507","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","article-title":"Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: A 2-year randomised clinical trial","volume":"104","author":"Lam","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"R19-20260507","doi-asserted-by":"crossref","first-page":"e2143781.","DOI":"10.1001\/jamanetworkopen.2021.43781","article-title":"Evaluation of an optical defocus treatment for myopia progression among schoolchildren during the COVID-19 pandemic","volume":"5","author":"Choi","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R20-20260507","first-page":"1110","article-title":"Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: Results of a 3-year follow-up study","volume":"106","author":"Lam","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"13","key":"R21-20260507","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.1038\/s41598-023-32700-7","article-title":"Long-term myopia control effect and safety in children wearing DIMS spectacle lenses for 6 years","volume":"4","author":"Lam","year":"2023","journal-title":"Sci Rep"},{"key":"R22-20260507","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/ICL.0000000000000571","article-title":"An update of eye shape and myopia","volume":"45","author":"Matsumura","year":"2019","journal-title":"Eye Contact Lens"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_2378_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:21:37Z","timestamp":1787768497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_2378_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":22,"journal-issue":{"issue":"Suppl 4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_2378_23","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]},"assertion":[{"value":"2023-08-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}